Innovative Pharmaceutical Biotech (HKSE:00399) Gross Margin % : 10.20% (As of Sep. 2023)

Innovative Pharmaceutical Biotech Gross Margin % Chart

Innovative Pharmaceutical Biotech Annual Data
	Trend	Mar14	Mar15	Mar16	Mar17	Mar18	Mar19	Mar20	Mar21	Mar22	Mar23
Gross Margin %		Get a 7-Day Free Trial					9.40	11.11	9.25	9.46	10.63

Innovative Pharmaceutical Biotech Semi-Annual Data
	Dec13	Sep14	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Gross Margin %	Get a 7-Day Free Trial															11.17	6.94	10.17	11.10	10.20

Competitive Comparison of Innovative Pharmaceutical Biotech's Gross Margin %

For the Household & Personal Products subindustry, Innovative Pharmaceutical Biotech's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Innovative Pharmaceutical Biotech's Gross Margin % Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Innovative Pharmaceutical Biotech's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Innovative Pharmaceutical Biotech's Gross Margin % falls into.

Innovative Pharmaceutical Biotech Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Innovative Pharmaceutical Biotech's Gross Margin for the fiscal year that ended in Mar. 2023 is calculated as

Innovative Pharmaceutical Biotech's Gross Margin for the quarter that ended in Sep. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.

Innovative Pharmaceutical Biotech  (HKSE:00399) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Innovative Pharmaceutical Biotech had a gross margin of 10.20% for the quarter that ended in Sep. 2023 => No sustainable competitive advantage

Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.

Innovative Pharmaceutical Biotech Gross Margin % Related Terms

Thank you for viewing the detailed overview of Innovative Pharmaceutical Biotech's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Innovative Pharmaceutical Biotech (HKSE:00399) Business Description